Over the past 12 months, 1 insider at Quoin Pharmaceuticals, Ltd. filed 1 open-market SEC Form 4 transaction on QNRX: 1 purchase worth $129K and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Oct 14, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 14, 25 | Dennis LangerDirector | BUY | 15.2K | $8.49 | $129K |
| Dec 23, 24 | Denise P. CarterChief Operating Officer | BUY | 555.6K | $0.45 | $250K |
| Dec 23, 24 | Anthony James CulverwellDirector | BUY | 100.0K | $0.45 | $45K |
| Dec 23, 24 | Gordon DunnChief Financial Officer | BUY | 122.2K | $0.45 | $55K |
| Dec 23, 24 | Michael MyersChief Executive Officer | BUY | 555.6K | $0.45 | $250K |
| Sep 10, 24 | Gordon DunnChief Financial Officer | BUY | 10.0K | $0.91 | $9K |
| Sep 9, 24 | Gordon DunnChief Financial Officer | BUY | 4.0K | $0.80 | $3K |
| Sep 4, 24 | Denise P. CarterChief Operating Officer | BUY | 23.0K | $0.80 | $18K |
| Sep 4, 24 | Michael MyersChief Executive Officer | BUY | 23.6K | $0.80 | $19K |
| Sep 3, 24 | Denise P. CarterChief Operating Officer | BUY | 4.1K | $0.66 | $3K |
| Sep 3, 24 | Michael MyersChief Executive Officer | BUY | 800 | $0.62 | $496 |
| Jun 7, 24 | Dennis LangerDirector | SELL | 297 | $0.73 | $217 |
Over the past 12 months, insiders at Quoin Pharmaceuticals, Ltd. filed 1 open-market purchase worth $129K and 0 sales worth $0 on QNRX, which makes them net buyers over the period. The most recent Form 4 was filed on Oct 14, 25.
The largest recent open-market QNRX insider purchase in our data was $250K by Denise P. Carter, Chief Operating Officer, filed on Dec 23, 24.
1 different insider at Quoin Pharmaceuticals, Ltd. filed open-market SEC Form 4 transactions on QNRX over the last 12 months.
InsiderTape plots every QNRX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Quoin Pharmaceuticals, Ltd. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →